Overview
Jonathan Amos is a Rheumatologist in Overland Park, Kansas. Dr. Amos is rated as an Experienced provider by MediFind in the treatment of Psoriasis. His top areas of expertise are Calcium Pyrophosphate Arthritis, Rheumatoid Arthritis (RA), Juvenile Temporal Arteritis, and Giant Cell Arteritis (GCA). Dr. Amos is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5701 West 119th Street Building D Suite 209, Overland Park, KS 66209
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Kansas City Physician Partners Inc
Christopher Koenig is a Rheumatologist in Olathe, Kansas. Dr. Koenig is rated as a Distinguished provider by MediFind in the treatment of Psoriasis. His top areas of expertise are Rheumatoid Arthritis (RA), Psoriasis, Raynaud Phenomenon, and Polymyalgia Rheumatica. Dr. Koenig is currently accepting new patients.
Kansas City Physician Partners Inc
Michael Smith is a Rheumatologist in Kansas City, Missouri. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Psoriasis. His top areas of expertise are Rheumatoid Arthritis (RA), Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis. Dr. Smith is currently accepting new patients.
Kansas City Physician Partners Inc
Kalista Engelman is a Rheumatologist in Kansas City, Missouri. Dr. Engelman is rated as a Distinguished provider by MediFind in the treatment of Psoriasis. Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis. Dr. Engelman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Calcium Pyrophosphate Arthritis
- Rheumatoid Arthritis (RA)Dr. Amos isAdvanced. Learn about Rheumatoid Arthritis (RA).
- Experienced
- Giant Cell Arteritis (GCA)Dr. Amos isExperienced. Learn about Giant Cell Arteritis (GCA).
- Juvenile Temporal ArteritisDr. Amos isExperienced. Learn about Juvenile Temporal Arteritis.
- Necrotizing VasculitisDr. Amos isExperienced. Learn about Necrotizing Vasculitis.
- Polymyalgia RheumaticaDr. Amos isExperienced. Learn about Polymyalgia Rheumatica.
- PsoriasisDr. Amos isExperienced. Learn about Psoriasis.
- Psoriatic ArthritisDr. Amos isExperienced. Learn about Psoriatic Arthritis.